As we enter a new earnings season, there are several reasons for optimism about the economy. However, potential headwinds ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

Doctors say the situation forces them to get creative in treating patients, but there’s hope that prices may fall more in the ...

California legislators have pulled Medicaid coverage for pricey weight loss drugs like Zepbound to patch a $12 billion budget hole. This move carves out an exception for diabetes treatment, so the ...

Pharmaceutical giant Eli Lilly that new preliminary research indicates its medication Zepbound helps patients lose more weight in a shorter time frame compared to Novo Nordisk's Wegovy. According ...

In 2030, Evaluate projects Lilly’s diabetes treatment Mounjaro will be the world’s top-selling drug, generating $36 billion, while the company’s obesity medicine Zepbound will be the third ...

Eli Lilly and Co. hosted its first “Ask Me Anything” session on the popular online forum Reddit on Monday, featuring a question-and-answer session with a Lilly executive about insurance ...

Scholar Rock’s investigational spinal muscular atrophy drug helped patients taking Eli Lilly’s obesity blockbuster Zepbound maintain muscle mass, offering another avenue to reach a key goal ...

Lilly will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying customers on its website starting early august, the Indianapolis-based drugmaker said Monday. With the ...

Eli Lilly will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying customers on its website starting early August, the U.S. drugmaker said on Monday.

Eli Lilly announced on Monday it will soon make the two highest doses of its popular weight-loss drug Zepbound available for self-paying customers on its website. Starting in August, 12.5 ...